Our study demonstrates that immunization with either pVAX-ROP6 or pVAX-MIC12 induces robust Th1-polarized cellular immunity, significant humoral responses as well as enhanced protection against both acute (RH strain) and chronic (PRU strain) infection. This evidence concerns the gene MICOS13 and infection.